SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 102 filers reported holding SYROS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 7.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $135,000 | -26.6% | 30,162 | -10.4% | 0.01% | -31.2% |
| Q2 2021 | $184,000 | +44.9% | 33,676 | +97.8% | 0.02% | +33.3% |
| Q1 2021 | $127,000 | -40.4% | 17,026 | -13.2% | 0.01% | -47.8% |
| Q4 2020 | $213,000 | +131.5% | 19,606 | +46.9% | 0.02% | +360.0% |
| Q4 2019 | $92,000 | -60.3% | 13,351 | -67.9% | 0.01% | -66.7% |
| Q4 2018 | $232,000 | -17.7% | 41,587 | +117.3% | 0.02% | -78.9% |
| Q3 2017 | $282,000 | – | 19,139 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 4,806,656 | $58,449,000 | 19.02% |
| Casdin Capital, LLC | 182,141 | $2,215,000 | 1.83% |
| Aisling Capital LLC | 508,565 | $6,184,000 | 1.44% |
| Redmile Group, LLC | 948,440 | $11,533,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,812,778 | $22,043,000 | 0.91% |
| EcoR1 Capital, LLC | 63,596 | $773,000 | 0.25% |
| Eventide Asset Management | 150,000 | $1,824,000 | 0.12% |
| AWM Investment Company, Inc. | 47,550 | $578,000 | 0.11% |
| Weiss Multi-Strategy Advisers LLC | 49,000 | $596,000 | 0.03% |
| Baker Brothers Advisors | 204,465 | $2,486,000 | 0.02% |